Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Watchlist Manager
Avadel Pharmaceuticals PLC Logo
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Watchlist
Price: 21.31 USD -0.05% Market Closed
Market Cap: 2.1B USD

During the last 3 months Avadel Pharmaceuticals PLC insiders have not bought any shares, and have not sold any shares. The stock price has increased by 35% over this period (open performance analysis).

The last transaction was made on Jan 21, 2025 by Palczuk Linda , who bought 39.6k USD worth of AVDL shares.

Last Transactions:
Palczuk Linda
$+39.6k
Thornton Peter J.
$+80.5k
Ende Eric J
$+235.2k
Mchugh Thomas S
$+24k
Mchugh Thomas S
$+52.4k
Glass Geoffrey Michael
$+99.6k
Divis Gregory J
$+3.9k
Divis Gregory J
$+95.8k
Palczuk Linda
$+30.6k
Mchugh Thomas S
$+29k
Mccamish Mark Anthony
$-1.1m
Mchugh Thomas S
$+28.9k
Mccamish Mark Anthony
$-432.6k
Glass Geoffrey Michael
$+187.6k
Divis Gregory J
$+132k
Ende Eric J
$+181.1k
Palczuk Linda
$+36.9k
Palczuk Linda
$+14.4k
Mchugh Thomas S
$+39k
Ende Eric J
$+156.1k
Glass Geoffrey Michael
$+96.3k
Ende Eric J
$+45.5k
Glass Geoffrey Michael
$+96.3k
Ende Eric J
$+32.4k
Thornton Peter J.
$+84.5k
Divis Gregory J
$+102.5k
Mchugh Thomas S
$+106.9k
Ende Eric J
$+36.7k
Palczuk Linda
$+16k
Mchugh Thomas S
$+24k
Mccamish Mark Anthony
$+305.2k
Ende Eric J
$+98.4k
View All Transactions

During the last 3 months Avadel Pharmaceuticals PLC insiders have not bought any shares, and have not sold any shares. The stock price has increased by 35% over this period (open performance analysis).

The last transaction was made on Jan 21, 2025 by Palczuk Linda , who bought 39.6k USD worth of AVDL shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
4
431.8k USD

Avadel Pharmaceuticals PLC
Insider Trading Chart

Avadel Pharmaceuticals PLC
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Avadel Pharmaceuticals PLC
Last Insider Transactions

Global
Insiders Monitor

Avadel Pharmaceuticals PLC
Glance View

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 66 full-time employees. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.

AVDL Intrinsic Value
24.83 USD
Undervaluation 14%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top